# Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a

> Inspection records and compliance data for Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. in Tokushima, None. Access full analysis and detailed observations.

---

## Details

- Name: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- FEI Number: 3002807834
- City: Tokushima
- State: None
- Country Name: Japan
- Address Line 1: 224-18, Kawauchi-Cho
- Zip Code: None

## Related Documents

- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2025-07-11](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/342d4cf7-7ad3-471a-9f9b-143ba211aca0) — source: FDA, date: July 11, 2025
- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2024-03-22](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ae73bd67-e93b-48af-8279-d731014ad321) — source: FDA, date: March 22, 2024
- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2024-03-22](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/eb2c8860-5edc-4644-ae11-0320df185e13) — source: FDA, date: March 22, 2024
- [FDA Inspection 1230640 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2024-03-22](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/ea9811aa-4107-436d-8e97-c772f1bed4ec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2024
- [483 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2019-09-10](https://www.keypedia.com/records/483/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/a01cb126-0c4a-4d16-a221-71b853e8bff1) — source: FDA, date: September 10, 2019
- [FDA Inspection 1106423 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2019-09-10](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/fffa5f62-5ff7-461b-9118-e485bdad04e8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 10, 2019
- [FDA Inspection 1049653 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2018-03-23](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/1ea9dae0-e4fd-4cb3-a59d-f9b811fe8d21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 23, 2018
- [FDA Inspection 958528 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2016-02-12](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/60ed0d58-008f-4b12-ae09-1c1bf67bb092) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2016
- [FDA Inspection 958528 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2016-02-12](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/2cdda799-d7ec-4742-a697-f15b470fe5c2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2016
- [FDA Inspection 888415 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2014-06-26](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/c8cf7e51-dcc4-42d0-9231-c9eac88f685a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2014
- [FDA Inspection 801261 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2012-07-09](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/4cd8eb1c-f8c4-4180-9694-2d4faf930625) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 9, 2012
- [FDA Inspection 754802 - Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. - 2011-10-27](https://www.keypedia.com/records/fda_inspections/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/5d2961d3-836e-4c44-853a-116d64962a50) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2011

## Related Companies

- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [Wyeth Pharmaceutical Division of Wyeth Holdings LLC](https://www.keypedia.com/companies/wyeth-pharmaceutical-division-of-wyeth-holdings-llc/85fd73c7-1b97-4ac5-bc70-53dfb31c37e5)
- [Hovione LLC](https://www.keypedia.com/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/4112e7fd-7d8d-41bc-914f-6c705b2e47c7)
- [Amgen Singapore Manufacturing Pte Ltd](https://www.keypedia.com/companies/amgen-singapore-manufacturing-pte-ltd/ff869a15-a7c2-441a-8165-7fd77928331e)
- [Alexion Pharma International Operations Unlimited Co.](https://www.keypedia.com/companies/alexion-pharma-international-operations-unlimited-co/7c523c79-b4b1-4a47-8393-141753fd60e8)
- [Abbvie Biotechnology Ltd.](https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41)
- [Takeda Manufacturing Italia SPA](https://www.keypedia.com/companies/takeda-manufacturing-italia-spa/1998fa46-5f10-426b-b959-5378f2b887e1)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-y-philopoulos/3ac66ef5-f279-408d-bc21-028421ed1104)
- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)